- SSM Qual Res Health. 2022 Dec;2:100042.
- Taylor HA, Dowdy DW, Searle AR, Stennett AL, Dukhanin V, Zwerling AA, Merritt MW.
Archives: Publications
Publications
Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda
- Value Health. 2022 Jun;25(6):924-930.
- Thompson RR, Kityamuwesi A, Kuan A, Oyuku D, Tucker A, Ferguson O, Kunihira Tinka L, Crowder R, Turyahabwe S, Cattamanchi A, Dowdy DW, Katamba A, Sohn H.
Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach.
- Lancet Infect Dis. 2022 Aug 10:S1473-3099(22)00500-X. doi: 10.1016/S1473-3099(22)00500-X. Epub ahead of print.
- Ryckman T, Robsky K, Cilloni L, Zawedde-Muyanja S, Ananthakrishnan R, Kendall EA, Shrestha S, Turyahabwe S, Katamba A, Dowdy DW.
Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects
- PLoS One. 2022 Sep 26;17(9):e0270816.
- Gomes I, Dong C, Vandewalle P, Khan A, Creswell J, Dowdy D, Sohn H.
Quantifying Mycobacterium tuberculosis transmission dynamics across global settings: a systematic analysis
- Am J Epidemiol. 2022 Oct 13:kwac181. doi: 10.1093/aje/kwac181. Epub ahead of print.
- Smith J, Cohen T, Dowdy D, Shrestha S, Gandhi NR, Hill AN.
Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses
- Value Health. 2022 Oct 29:S1098-3015(22)04688-5.
- Dowdy DW, Thompson RR, Kityamuwesi A, Crowder R, Cattamanchi A, Katamba A, Sohn H.
Tuberculosis treatment adherence in the era of COVID-19.”
- BMC Infect Dis. 2022 Oct 26;22(1):800. doi: 10.1186/s12879-022-07787-4. PMID: 36289485; PMCID: PMC9607764.
- Lippincott CK, Perry A, Munk E, Maltas G, Shah M.
Tuberculosis Epidemiologic Studies Consortium. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States
- Clin Infect Dis. 2022 Nov 14;75(10):1792-1799. doi: 10.1093/cid/ciac248. PMID: 35363249.
- Holzman SB, Perry A, Saleeb P, Pyan A, Keh C, Salcedo K, Narita M, Ahmed A, Miller TL, Pettit AC, Khurana R, Whipple M, Katz D, Largen A, Krueger A, Shah M.
Diagnostic biomarkers for active tuberculosis: progress and challenges
- EMBO Mol Med. 2022 Oct 31;e14088. doi: 10.15252/emmm.202114088
- Betânia M F Nogueira # 1 2 3, Sonya Krishnan # 4, Beatriz Barreto-Duarte 3 5 6 7, Mariana Araújo-Pereira 3 7 8, Artur T L Queiroz 2 9, Jerrold J Ellner 10, Padmini Salgame 10, Thomas J Scriba 11, Timothy R Sterling 12, Amita Gupta 4, Bruno B Andrade 3 5 7 8 13 14
An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis
Front Immunol. 2022 Sep 16;13:972266. doi: 10.3389/fimmu.2022.972266. eCollection 2022.
Styliani Karanika 1 2, James T Gordy 3, Pranita Neupane 1 2, Theodoros Karantanos 4, Jennie Ruelas Castillo 1 2, Darla Quijada 1 2, Kaitlyn Comstock 3, Avinaash K Sandhu 3, Aakanksha R Kapoor 1 3, Yinan Hui 3, Samuel K Ayeh 1 2, Rokeya Tasneen 1 2, Stefanie Krug 1 2, Carina Danchik 1 2, Tianyin Wang 3, Courtney Schill 3, Richard B Markham 3, Petros C Karakousis 1 2